NIH Pauses Eli Lilly COVID-19 Antibody Trial Due to ‘Safety Concerns’
NIH Pauses Eli Lilly COVID-19 Antibody Trial Due to ‘Safety Concerns’ By: Jeremy Loffredo The National Institutes of Health (NIH) Tuesday paused enrollment in the late-stage clinical trial for Eli Lilly’s COVID-19 antibody treatment. The […]